Skip to Main Content

Publications

1–10 of 11 results

  1. Polyamine Metabolism as a Metabolic Vulnerability in Prostate Cancer Treated with Supraphysiological Androgens

    Alizadeh-Ghodsi M, Goldstein AS

    Cancer Research. 2026;86(5), 1095-1097.

    Goldstein Andrew Goldstein
    2026

  2. Polyamine Metabolism as a Metabolic Vulnerability in Prostate Cancer Treated with Supraphysiological Androgens

    Alizadeh-Ghodsi M, Goldstein AS

    Cancer Research. 2026;86(5), 1095-1097.

    Goldstein
    2026

  3. OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance

    Bernard MJ, Gallardo A, Ruiz A, Diaz JA, Nunley NM, Dove RN, Zhang S, Lee E, Heering KY, Varuzhanyan G, Bopardikar S, Hashimoto T, Agrawal R, Smith CM, Wilde BR, Matulionis N, Richards HM, Lee SCES, Sharifi MN, Lang JM, Zhao SG, Witte ON, Haffner MC, Shackelford DB, Boutros PC, Christofk HR, Goldstein AS

    Molecular Cancer Research. 2026;24(5), 356-375.

    Goldstein
    2026

  4. Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment

    Giafaglione JM, Crowell PD, Delcourt AML, Hashimoto T, Ha SM, Atmakuri A, Nunley NM, Dang RMA, Tian M, Diaz JA, Tika E, Payne MC, Burkhart DL, Li D, Navone NM, Corey E, Nelson PS, Lin NYC, Blanpain C, Ellis L, Boutros PC, Goldstein AS

    Nature Cell Biology. 2023;25(12), 1821-1832.

    Goldstein
    2023

  5. MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

    Crowell PD, Giafaglione JM, Jones AE, Nunley NM, Hashimoto T, Delcourt AML, Petcherski A, Agrawal R, Bernard MJ, Diaz JA, Heering KY, Huang RR, Low JY, Matulionis N, Navone NM, Ye H, Zoubeidi A, Christofk HR, Rettig MB, Reiter RE, Haffner MC, Boutros PC, Shirihai OS, Divakaruni AS, Goldstein AS

    Cell Reports. 2023;42(10), 113221.

    Goldstein
    2023

  6. Prostatic proliferative inflammatory atrophy: welcome to the club†

    Bernard MJ, Smith CM, Goldstein AS

    The Journal of Pathology. 2023;261(4), 375-377.

    Goldstein
    2023

  7. Highly multiplexed immune profiling throughout adulthood reveals kinetics of lymphocyte infiltration in the aging mouse prostate

    Fox JJ, Hashimoto T, Navarro HI, Garcia AJ, Shou BL, Goldstein AS

    Aging. 2023;15(9), 3356-3380.

    Goldstein
    2023

  8. Microwell‐based flow culture increases viability and restores drug response in prostate cancer spheroids

    Payne MC, Ho S, Hashimoto T, Imboden S, Diaz JA, Lee BS, Rupert MJ, Cai NY, Goldstein AS, Lin NYC

    Biotechnology Journal. 2023;18(6).

    Goldstein
    2023

  9. Androgen Drives the Expression of SARS-CoV-2 Entry Proteins in Sinonasal Tissue

    Huang RR, Giafaglione JM, Hashimoto T, Zhang L, Yu W, Rao J, Russo JW, Balk SP, Nickols NG, Rettig MB, Goldstein A, Ye H

    Journal of Clinical and Translational Pathology. 2023;000(000), 000-000.

    Goldstein
    2023

  10. Mass cytometry reveals species-specific differences and a new level of complexity for immune cells in the prostate.

    Fox JJ, Navarro HI, Hashimoto T, Garcia AJ, Goldstein AS

    Am J Clin Exp Urol. 2019;7(4), 281-296.

    Goldstein
    2019